- Home
- IFBD vs APVO Comparison
IFBD vs APVO Comparison
Compare IFBD & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFBD
- APVO
- Stock Information
- Founded
- IFBD 2001
- APVO 2016
- Country
- IFBD China
- APVO United States
- Employees
- IFBD N/A
- APVO N/A
- Industry
- IFBD Computer Software: Prepackaged Software
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- IFBD Technology
- APVO Health Care
- Exchange
- IFBD Nasdaq
- APVO Nasdaq
- Market Cap
- IFBD 4.3M
- APVO 3.7M
- IPO Year
- IFBD 2021
- APVO N/A
- Fundamental
- Price
- IFBD $1.88
- APVO $0.21
- Analyst Decision
- IFBD
- APVO Strong Buy
- Analyst Count
- IFBD 0
- APVO 1
- Target Price
- IFBD N/A
- APVO $8.00
- AVG Volume (30 Days)
- IFBD 33.2K
- APVO 17.5M
- Earning Date
- IFBD 11-26-2024
- APVO 11-07-2024
- Dividend Yield
- IFBD N/A
- APVO N/A
- EPS Growth
- IFBD N/A
- APVO N/A
- EPS
- IFBD N/A
- APVO N/A
- Revenue
- IFBD $280,000.00
- APVO N/A
- Revenue This Year
- IFBD N/A
- APVO N/A
- Revenue Next Year
- IFBD N/A
- APVO N/A
- P/E Ratio
- IFBD N/A
- APVO N/A
- Revenue Growth
- IFBD N/A
- APVO N/A
- 52 Week Low
- IFBD $1.63
- APVO $0.14
- 52 Week High
- IFBD $54.64
- APVO $10.80
- Technical
- Relative Strength Index (RSI)
- IFBD 43.08
- APVO 43.68
- Support Level
- IFBD $1.98
- APVO $0.24
- Resistance Level
- IFBD $2.30
- APVO $0.33
- Average True Range (ATR)
- IFBD 0.16
- APVO 0.04
- MACD
- IFBD -0.00
- APVO -0.01
- Stochastic Oscillator
- IFBD 5.53
- APVO 0.70
About IFBD Infobird Co. Ltd
Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service, provider of innovative AI-powered, or artificial intelligence enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process including pre-sales and sales activities and post-sales customer support. It also offers AI-powered cloud-based sales force management software including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performances of agents.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.